Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san francisco blog main
accelerator
airbnb
amazon web services (aws)
artificial intelligence (a.i.)
astellas pharma
athelas
atlas venture
atomwise
audentes therapeutics
avidity biosciences
benchling
biotech
biotechnology
bluebird bio
boston
cancer
clinical trials
coinbase
coworking
cruise
culture biosciences
data analytics
deals
detroit blog main
detroit top stories
doordash
dropbox
drug development
drugs
duchenne muscular dystrophy
dyne therapeutics
entrepreneurship
What
ago
2
×
biotechs
2
×
admits
big
classes
combinator
companies
considering
data
diseases
drug
dug
dyne
early
expected
experimental
eyes
genetic
having
humans
incubator
ipo
ipos
life
long
medicines
muscle
previously
rare
reach
sciences
sizable
started
startup
tech
therapeutics
they’re
welcome
worked
years
Language
unset
Current search:
biotechs
×
ago
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
